Nuclear factor kB (NFkB) plays a pivotal role in the coordinated transactivation of a series of genes of cytokines and adhesion molecules that are highly involved in the onset of acute rejection in organ transplantation. We previously developed decoy cis-elements oligo deoxyribonucleic acid against NFkB (NFkB-decoy) that effectively inhibited the activation of major inflammatory mediators in vitro and in vivo. Accordingly, we hypothesized that transfection of NFkB-decoy into the donor kidney would prevent acute rejection and prolong graft survival, and thus provide effective therapy for renal acute rejection. To transfect NFkB-decoy, we employed a novel approach using ultrasound exposure with an echocardiographic contrast agent, Optison, and clearly demonstrated successful transfection of NFkB-decoy into renal tissue. The therapeutic effect of NFkB-decoy on renal allografts was then evaluated in a rat renal allograft model (Wistar-Lewis). In the control group, graft function significantly deteriorated with marked destruction of renal tissue, accompanied by increased production of major inflammatory mediators, and all animals died of renal failure by 9 days. In contrast, graft function (serum creatinine on day 2, NFkB-treated: 0.9770.16 versus control: 1.8470.23 mg/dl, Po0.01) and histological structure were well preserved with significantly decreased expression of NFkB-regulated cytokines and adhesion molecules, including IL-1, iNOS, MCP-1, TNF-a, and ICAM-1, in allografts transfected with NFkB-decoy. As a result, animal survival was significantly prolonged in this group as compared to controls (14.275.2 versus 7.171.2 days, Po0.01). Thus, we established a novel ultrasound-Optison-mediated gene transfection approach and demonstrated the significant prolongation of graft survival by the successful transfection of NFkB-decoy into the donor kidney in a rat renal allograft model. Gene Therapy (2003) 10, 415-425.
Introduction
Acute allograft rejection is a T-cell-mediated immunological phenomenon, involving numerous inflammatory mediators and adhesion molecules. 1 The development of these complex events requires the activation of multiple transcription factors in a synergistic coordinated manner. 2, 3 Nuclear factor kB (NFkB) is one of such transcription factors for genes whose products are critical for inflammation and immunity. 4 It rapidly translocates from the cytoplasm to the nucleus in response to a variety of extracellular signals and plays a pivotal role in the regulation of inflammatory changes by inducing coordinated transactivation of genes of major inflammatory mediators such as IL-1, IL-6, iNOS, and TNF-a [5] [6] [7] [8] [9] [10] [11] and adhesion molecules such as ICAM-1 and VCAM-1. [12] [13] [14] Cooper et al demonstrated a time-dependent increase in the DNA-binding activity of NFkB, which peaked at 3 days before rejection, in a rat cardiac allograft model. However, administration of pyrrolidine dithiocarbamate (PDTC), a potent inhibitor of NFkB, markedly prolonged graft survival with a decreased peak of NFkB activity in this model. 15 The immunosuppressive agents FK506 and cyclosporin A (CsA) are reported to switch off gene transcription by inhibiting a key signaling phosphatase, calcinurin, which is involved in the activation of NFkB. [16] [17] [18] Glucocorticoid, another major immunosuppressive agent, is also believed to work partly via inhibition of NFkB activation. 19, 20 Accumulating evidence clearly demonstrates that blocking the activity of NFkB might arrest the progression of acute rejection by interrupting the activation of genes of major inflammatory cytokines and adhesion molecules. Despite the development of numerous drugs to modulate NFkB activity, systemic administration of those drugs is still limited by their side effects with long-term administration. Induction of local immunosuppression in the grafted organ would be ideal, and is the next issue in organ transplantation.
Synthetic double-stranded DNA with high affinity for a target transcription factor introduced as a 'decoy' ciselement is a novel strategy for interruption of intranuclear signal transduction. It blocks the binding of nuclear factors to promoter regions of targeted genes, resulting in inhibition of gene transactivation in vitro and in vivo. 21, 22 Such a decoy strategy has been proposed for the treatment of some human diseases represented by animal models. 23, 24 Recently, we developed decoy ciselements oligo deoxyribonucleic acid against NFkB (NFkB-decoy), which inhibited the production of major inflammatory cytokines and expression of adhesion molecules in vitro and in vivo. [25] [26] [27] [28] [29] [30] Accordingly, we hypothesized that transfection of a sufficient quantity of NFkB-decoy into the donor kidney would prevent transactivation of gene expression of essential cytokines and adhesion molecules and thereby protect against the establishment and progression of acute rejection. We therefore conducted the present study, and here demonstrated successful transfection of NFkB-decoy into the donor kidney using a novel ultrasound-mediated transfection method, and significant prolongation of graft survival in a rat renal allograft model.
Results
Optimization of ultrasound-Optison-mediated gene transfection procedure using luciferase reporter gene in rat renal autografts
We performed luciferase gene transfection into rat renal autografts to develop the optimal conditions for ultrasound-Optison-mediated transfection into renal tissue. We first examined the effect of ultrasound exposure according to its duration on the transfection efficiency. The luciferase reporter gene (50 mg) was infused into the kidney followed by various durations of ultrasound exposure (0.5, 1, 2, or 8 min). Autografts were harvested on day 4 after the engraftment for luciferase assay. Ultrasound application significantly enhanced transfection of luciferase reporter gene in proportion to its duration up to 1 min, as shown in Figure 1A -a. However, the efficacy of ultrasound exposure was not significantly different, between 1 and 2 min. In addition, 2 min of ultrasound exposure caused marked tissue injury, while no apparent injury was observed until 1 min. We therefore decided to apply ultrasound irradiation for 1 min. We next examined the effect of Optison with ultrasound application on the transfection efficiency.
Optison was added in the perfusion solution at three different concentrations (0%, 10%, or 25%), and applied b - Figure 1 Optimization of ultrasound-Optison-mediated gene transfection procedure into renal tissue. (A) The efficacy of ultrasound exposure and the use of Optison for gene transfection into renal autografts evaluated by luciferase assay. The luciferase reporter gene (50 mg) was infused into the kidney followed by various durations of ultrasound exposure (0.5, 1, 2, or 8 min). Autografts were harvested on day 4 after the engraftment for luciferase assay. Ultrasound exposure significantly enhanced the transfection of luciferase reporter gene into renal tissue in proportion to its duration up to 1 min, while the efficacy of ultrasound exposure was not significantly different between 1 min and 2 min (a). Optison was added in the perfusion solution at three different concentrations (0%, 10%, or 25%), and applied with 1 min of ultrasound irradiation. The addition of Optison significantly enhanced gene transfection of the luciferase reporter gene when Optison was added at a concentration of 10% or 25% (b). (B) The efficacy of ultrasound exposure and Optison for NFkB-decoy transfection into renal allografts evaluated by fluorescence intensity. The 100 mg FITClabeled NFkB-decoy was transfected into renal allografts in a similar manner to how we performed luciferase reporter gene transfection. The allografts were harvested on day 4 after transplantation, and the transfection efficiency was evaluated by examining the expression of FITC in the renal tissue under fluorescence microscopy. Few FITC-stained cells were observed in glomeruli (a) and in tubules (b) with 30 s of ultrasound exposure without the addition of Optison. However, the expression of FITC-stained cells increased both in the glomeruli (c) and tubules (d) with 1 min of ultrasound exposure without Optison. Moreover, the fluorescence intensity was further enhanced in both the glomeruli (e) and tubules (f) in the allografts with the use of Optison at 10%. Original magnification, Â 400 in (a-f). These results indicate that transfection of NFkB-decoy into the donor kidney using ultrasound application has a beneficial effect to prolong graft survival. In addition, the use of Optison significantly enhances the efficacy of ultrasound in NFkB-decoy transfection and prolongation of animal survival. There were no significant differences in survival time among Groups 3-5.
Graft function
Graft function was assessed serially by measuring urine volume and serum creatinine levels, and urinary sediment was examined in each sample. Functional data clearly validated the data on graft survival, and confirmed the beneficial effects of NFkB-decoy on renal transplantation. The recipients of allografts treated with scrambled decoy oligo deoxyribonucleic acid (SC-decoy) (Group 3) showed marked hematuria by day 2 after transplantation. Urine volume significantly decreased by day 4 (M7s.d.¼6.1373.89 versus 17.2976.10 ml/day in Group 1, Po0.01, n¼10); most animals became anuric by day 6 (1.2971.12 ml/day, n¼9). In contrast to control animals, most of the recipients bearing allografts treated with NFkB-decoy (Group 1) maintained a normal urine 
The donor kidneys of recipients in each group were treated as follows. Group 1: 100 mg NFkB-decoy (NFkB) dissolved in 0.5 ml saline containing 10% Optison was infused into the donor kidney, followed by ultrasound exposure for 1 min (n=21). Group 2: Donor kidneys were treated with the same amount of NFkB-decoy with ultrasound exposure, but without Optison (n=21). Group 3: Donor kidneys were treated with 100 mg of SC-decoy (SC) with 10% Optison with ultrasound exposure (n=21). Group 4: Donor kidneys were treated with the same amount of SC-decoy with ultrasound exposure, but without Optison (n>10). Group 5: Donor kidneys did not receive any treatment (n=21).
NFkB-decoy prevents acute rejection in renal allografts H Azuma et al volume without hematuria by day 6 (13.9376.42 ml/day, Po0.01, n¼10) ( Figure 3a ). The serum creatinine data corroborated these results. In the control recipients, serum creatinine was significantly elevated by day 2 as compared to that of recipients in Group 1 (M7s.d.¼1.8470.23 versus 0.9770.16 mg/dl, Po0.01, n¼10) (Figure 3b ), and increased progressively thereafter until death. In contrast to control animals, the values in Group 1 recipients were significantly lower at all time points. These data on graft function clearly confirmed that the animals died of renal failure and corroborated the data on graft survival. Significantly reduced cellular infiltration and expression of adhesion molecules and cytokine production in allografts treated with NFkB-decoy
We performed a detailed immunohistologic evaluation of allografts treated with NFkB-decoy (Group 1) harvested on day 4, and compared them with acutely rejected control grafts (Group 3). Representative pictures of immunohistologically stained sections are shown in Figure 5 , and quantitative evaluation is presented in Table 2 . In acutely rejected control renal allografts, numerous ED-1+ mononuclear cells as well as CD4+ cells infiltrated into the glomeruli and tubulo-interstitium, especially the adventitia, and periglomerular area (Figure 5a-c, Table 2 ). The production of inflammatory mediators that are known to be activated by NFkB, including IL-1, MCP-1, and TNF-a, markedly increased along with the infiltration of mononuclear cells ( Figure  5d -f, Table 2 ). Expression of ICAM-1 was frequently detected in glomerular endothelial cells, as well as the endothelium of large intrarenal vessels ( Figure 5g , Table  2 ). In contrast to the controls, infiltration of ED-1+ macrophages and CD4+ mononuclear cells was significantly decreased in allogafts treated with NFkB-decoy (Figure 5h-j, Table 2 ). The production of inflammatory mediators, including IL-1, MCP-1, and TNF-a, was markedly suppressed, associated with decreased cellular infiltration ( Figure 5k and l, Table 2 ). The expression of ICAM-1 was significantly weaker in allografts treated with NFkB-decoy (Figure 5m-p, Table 2 ).
Reverse transcription-polymerase chain reaction (RT-PCR) assay
We evaluated the production of mRNA of major inflammatory mediators and adhesion molecules in the allografts from Groups 1 and 3 harvested on day 4, by semiquantitative RT-PCR method. The results were basically consistent with the data on the immunohistological analysis. The production of mRNA of major NFkB-decoy prevents acute rejection in renal allografts H Azuma et al Figure 4 Histological sections (PAS staining) of allografts harvested on day 2, 4, and 6 in control group (Group 3) and NFkB-decoy-treated group (Group 1). Allografts from control animals harvested on day 2 after transplantation showed widespread infiltration of mononuclear cells in large numbers (a). Many glomeruli showed marked mononuclear cell infiltration with a large amount of mesangial matrix (b). Most tubules were structurally deformed, with marked protein deposition and intratubular casts (c). On day 4, cellular infiltration had become more florid in all areas, with marked disruption of normal renal architecture and hemorrhage (d). Some glomeruli (e) and tubules (f) showed severe structural deformity and necrosis, with infiltration of numerous mononuclear cells. By day 6, the changes had undergone rapid and aggressive progression, showing severe structural deformity with widespread necrotic tissue (g); most glomeruli (h) and tubules (i) had undergone severe necrosis. In contrast, allografts treated with NFkB-decoy were markedly well preserved with few infiltrating mononuclear cells throughout the graft tissue on day 2 (j). Most glomeruli showed a normal appearance (k). The tubular structure remained mostly normal, with no apparent protein deposition (l). No evident changes were observed in the interstitial area (m), as well as in the glomeruli (n) and tubules (o) in the allografts on day 4. On day 6, though a small number of infiltrating cells were observed in the interstitial area (p), most glomeruli (q) and tubules (r) showed minor changes. Original magnification: Â 100 in (a, d, g, j, m and p) Â 400 in (b, c, e, f, h, i, k, l, n, o, q, and r).
NFkB-decoy prevents acute rejection in renal allografts H Azuma et al Figure 5 Immunohistological studies of renal allografts. We performed a detailed immunohistological evaluation of NFkB-decoy-treated allografts (Group 1) harvested on day 4 after transplantation, and compared them with acutely rejected control allografts (Group 3). A number of infiltrating CD4+ mononuclear cells were observed in the acutely rejected control renal allografts, especially in the tubulo-interstitium (a), glomeruli (b), and periarterial area (c). Intense expression of TNF-a appeared in the glomeruli (d) and in the medulla (e). Likewise, the production of MCP-1 was augmented, along with numerous infiltrating mononuclear cells (f). In addition, there was dense expression of ICAM-1 in the endothelium of large intrarenal vessels (g). In contrast to controls, only a minor influx of CD4+ mononuclear cells was noted in allografts treated with NFkB-decoy (h-j). The production of TNF-a was markedly decreased in the cortex (k) and medulla (l). The production of MCP-1 was markedly decreased, associated with decreased mononuclear cell infiltration (m). In addition, the expression of ICAM-1 was only faint in the endothelium of arteries (n). Original magnification: Â 100 in (a and h); Â 400 in (b-g and i-n). NFkB-decoy prevents acute rejection in renal allografts H Azuma et al inflammatory cell mediators, which are driven by NFkB including iNOS, IL-1, MCP-1, and TNF-a, was significantly decreased in allografts treated with NFkB-decoy (Group 1) as compared to that in controls (Group 3) (Po0.01, Figure 6a and b) . Likewise, the mRNA production of adhesion molecules, especially ICAM-1, was significantly decreased in the allogafts from Group 1 as compared to controls. Interestingly, however, there was no significant difference in the production of TGFb1, which may not be directly regulated by NFkB, between the groups.
Discussion
Progressive improvements in immunosuppression have led to a marked increase in the success rate of organ transplantation and established renal transplantation as a routine treatment for chronic renal failure. However, several severe adverse effects due to the systemic use of immunosuppressive agents, such as severe infection or development of malignancy, have remained perplexing problems in the clinical setting. Induction of immunological tolerance or local immunosuppression in the grafted organ would be ideal, and is the next issue in organ transplantation. A number of studies have recently been performed using novel gene transfer technology, eg, viral vectors, especially adenovirus and hemagglutinating visus of Japan (HVJ) liposomes. Nevertheless, no safe and convincing virus-mediated procedure to produce local immunosuppression in the grafted organ has been established for renal transplantation. Adenovirus is the most popular vector for gene transfection, because of its high transfection efficiency and ease of handling. However, gene transfection into renal tissue using an adenoviral vector is one of the most difficult procedures, and still has many disadvantages such as local immunogenicity, production of neutralizing antibodies, and sometimes, lethal toxicity. HVJ-liposome-mediated method is an alternative option for a viral gene-transfection procedure. We have been working on this issue for a long time, and previously reported the successful transfection of NFkB-decoy into the kidney in a glomerulonephritis model. 29 However, its safety issues and storage methods have not been established clinically, and its transfection efficiency may not be as high as that of this newly established ultrasound-Optison-mediated technique. In the present study, FITC signals, which indicate successful transfection of NFkB-decoy, were observed in more than 70-80% of total glomeruli and most tubular cells in the allografts treated with the ultrasound-Optison-mediated method. In contrast, the ratio of glomeruli transfected with NFkB-decoy to total glomeruli was only 40-50% with HVJ-liposome-mediated approach. 29 Furthermore, our preliminary experiments using luciferase reporter gene demonstrated significantly higher transfection efficiency when transfection was performed with the ultrasound-Optison-mediated method as compared to the HVJ-liposome method. The luciferase activity was around 300 light units (M7s.d.¼295791 U, n¼7) when transfection was performed with HVJ-liposome method. In contrast, the mean value of luciferase activity was 3691 light units (M7s.d.¼36917658 U) when transfection was performed with the ultrasound-Optison-mediated method (1 min of ultrasound with 10% Optison). Thus, this newly established non-virus-mediated gene transfection technique, the ultrasound-Optison-mediated procedure, may provide successful gene transfection with high efficiency into renal tissue. This should be quite impressive for future clinical treatment and have potential as a new treatment strategy.
In contrast to the efficiency of this approach, overexposure of ultrasound or overdosage of contrast medium, which causes irreversible tissue injury, should be considered as a critical issue, and it is important to establish the optimal conditions for this novel technique. In the present study, we showed that ultrasound exposure increased the efficacy of gene transfection up Figure 6 Semiquantitative RT-PCR analysis. We evaluated the production of mRNA of major inflammatory mediators and adhesion molecules in allografts from Groups 1 and 3 harvested on day 4, by semiquantitative RT-PCR method. The production of mRNA of major inflammatory cytokines regulated by NFkB, including iNOS, IL-1, MCP-1, and TNF-a, was significantly decreased in allografts treated with NFkB-decoy (Group 1) as compared to that in controls (Group 3). Likewise, the mRNA production of adhesion molecules, especially ICAM-1, was significantly decreased in allografts from Group 1 as compared to controls (Group 3). Interestingly, however, the production of TGF-a1, which may not be directly regulated by NFkB, was not significantly affected by the treatment with NFkB-decoy, showing no significant difference in allografts between the groups (a). Representative data are shown in (b).
NFkB-decoy prevents acute rejection in renal allografts H Azuma et al to 1 min without notable tissue injury, while marked tissue injury occurred at 2 min. In addition, the use of Optison at a concentration of 10% or 25% significantly enhanced the efficiency of gene transfection, while severe tissue injury occurred at a concentration of 25%. Accordingly, we applied ultrasound exposure for 1 min, and a concentration of Optison at 10%. Thus, we determined the optimal conditions for ultrasoundOptison-mediated gene transfection into renal tissue, which should be of great value clinically.
It has been previously reported that ultrasound exposure increased the transfection efficiency of plasmid DNA into cultured cells, and its mechanism of action is thought to be increased cell membrane porosity. [31] [32] [33] Consistent with previous reports, the present study showed that ultrasound exposure induced transfection of decoy oligo deoxyribonucleic acid (ODN) in renal tissue, but its transfection efficiency was not high. We therefore modified the procedure using an echo-contrast agent, Optison, to increase the transfection efficiency, and demonstrated significantly improved transfection of decoy ODN in renal tissue. This concept is based on the previous observation that an echo-contrast agent, which contains gas bodies filled with perfluoropropane, lowered the threshold for the production of acoustic cavitation and enhanced the sonoporation of cultured cells with ultrasound exposure. [34] [35] [36] [37] [38] Interestingly, other echo-contrast agents, such as Levovist, which contains air-based gas bodies with different stabilization strategy, and Hexabrix, which does not contain gas bodies, did not enhance the transfection efficiency in our preliminary data (data not shown). Optison contains about 5 Â 10 8 ml À1 gas bodies 2-4.5 mm in diameter, which are filled with perfluoropropane and stabilized by a solid shell of heat-denatured human albumin. [36] [37] [38] Although further studies are necessary to investigate the exact molecular mechanism by which Optison enhances transfection efficiency, the molecular structure of gasfilled microsphere and their contents may be implicated in the mechanisms of action.
We then examined the therapeutic effect of NFkBdecoy on renal acute rejection using a rat renal transplantation model. Acute rejection in an allograft is principally a cell-mediated event associated with numerous cytokines and adhesion molecules. 1, 39 Transcriptional activation of the genes encoding these adhesion molecules and cytokines is tightly regulated by a transcription factor, NFkB. 4, 6, [9] [10] [11] 13, 40, 41 Under normal conditions, NFkB is usually present with IkB in the cytosol as an inactive complex. However, when grafts are exposed to stimuli after transplantation such as ischemia/reperfusion injury, cells may be activated to promote IkB-phosphorylation, which induces NFkB to translocate to the nucleus and to bind to the promoter region of genes of several major inflammatory mediators, such as IL-1, iNOS, and TNF-a, and upregulate their transcription. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] These products may also promote NFkB activation in a paracrine or autocrine fashion, and this in turn further upregulates the production of chemokines and the expression of surface molecules, establishing the so-called 'cytokine-adhesion molecule cascade', which further augments such inflammatory reaction and promotes the development of acute rejection. [41] [42] [43] [44] [45] As we previously reported, NFkB-decoy, which effectively binds NFkB and inhibits its activity, blocks the transactivation of genes for essential cytokines and adhesion molecules in vivo in several animal models of inflammatory disease as well as in vitro. 25, 26, [28] [29] [30] In addition, Vos et al demonstrated the successful transfection of NFkB-decoy using cationic liposome-mediated method, and that the expression of adhesion molecules, especially VCAM-1, was significantly decreased accompanied by markedly decreased infiltration of mononuclear cells, especially ED1+ macrophages, in a rat renal allograft model. 46 Accordingly, we hypothesized that the blockade of this self-augmenting cascade by NFkB-decoy should have powerful therapeutic potential for the prevention of acute rejection and prolongation of graft survival. Indeed, the present study clearly showed that transfection of NFkB-decoy powerfully protected kidney allografts from acute rejection and significantly prolonged animal survival. In addition, the effect of the treatment on graft survival paralleled the increased transfection of NFkB-decoy in the allografts. Furthermore, the expression of inflammatory mediators and adhesion molecules in the allografts analyzed by immunohistochemistry and RT-PCR clearly demonstrated that NFkB-regulated molecules including IL-1, iNOS, MCP-1, TNF-a, and ICAM-1, were markedly decreased by treatment with NFkB-decoy. On the contrary, the expression of TGF-b1, which may not be directly regulated by NFkB, was not apparently affected by the treatment with NFkB-decoy. These results indicate that the initial response mediated by NFkB is critical in the development of acute rejection, involving several pro-inflammatory mediators and adhesion molecules, which establish the cytokine-adhesion molecule cascade. The blockade of this cascade by NFkB-decoy may prevent the development of the progressive events leading to acute rejection, and contribute to the prolongation of graft survival.
Overall, we established a novel approach for gene transfection into a renal graft by applying ultrasound exposure with the use of an echocardiographic contrast agent, Optison. Moreover, we clearly demonstrated significant prolongation of graft survival by the successful transfection of NFkB-decoy into the donor kidney by this technique. Induction of local immunosuppression in the grafted organ, which would be the ideal situation for the organ transplantation, is potentially the mechanism of action of this novel approach with NFkB-decoy, and thus, the therapeutic value of this approach warrants further attention and preclinical studies.
Materials and methods

Synthesis of ODN and selection of sequence targets
Sequences of the phosphorothionate ODN used were as follows; NFkB-decoy: 5 0 -CCT TGA AGG GAT TTC CCT CC-3 0 , 3 0 -GGA ACT TCC CTA AAG GGA GG-5 0 and SCdecoy: 5 0 -TTG CCG TAC CTG ACT TAG CC-3 0 , 3 0 -AAC GGC ATG GAC TGA ATC GG-5 0 . NFkB-decoy has been shown to bind the NFkB transcription factor. Synthetic ODN were washed in 70% ethanol, dried, and dissolved in sterile Tris-EDTA buffer (10 mM tris (hydroxymethyl)-aminomethane, 1 mM ethylenediamine-tetraacetic acid). The supernatant was purified with an NAP 10 column (Pharmacia, Sweden) and quantitated by spectrophotometry. NFkB-decoy and SC-decoy were labeled with NFkB-decoy prevents acute rejection in renal allografts H Azuma et al FITC at the 3' and 5' ends with an endo-labeling kit (Nihon-Seifun, Tochigi, Japan).
Optimization of ultrasound-Optison-mediated transfection procedure using luciferase reporter gene in rat autografts
The renal vein and ureter in a Wistar rat were clamped using vascular clips after perfusion of the donor kidney. Then, 50 mg luciferase reporter gene was dissolved in 0.5 ml saline containing an echocardiographic contrast agent, Optison (Mallincrodt, St Louis, MO, USA; a commercially available contrast agent), at three different concentrations (0%, 10%, or 25%, n¼4/each concentration), and infused into the kidney through the renal artery. The kidney was removed and exposed to ultrasound using an ultrasound transducer (Celcom, Fukuoka, Japan) at 2 MHz carrier frequency in a water bath; signal intensity was 2.5 W/cm 2 and the exposure duration was varied from 30 s to 8 min. The kidney transfected with luciferase reporter gene was then autografted using microsurgical technique. The grafts were harvested on day 4, and luciferase activity was evaluated by luciferase assay.
Model of acute rejection in renal transplantation
Inbred 200-250 g male Lewis rats were used as graft recipients, and male Wistar rats served as donors. The left kidney was removed from a Wistar rat after perfusing it with ice-cold heparinized saline (1 U/ml) through the renal artery. The kidney was transplanted orthotopically into a bilaterally nephrectomized Lewis recipient by end-to-end anastomosis of the left renal vessels and the left ureter using microsurgical technique. During the procedure, the donor kidney was subjected to 30 min of cold ischemic injury. All experimental protocols were conducted in accordance with the policies of the Animal Ethics Committee of our institution. In this model, animals typically suffer acute rejection, become oligo-or anuric, and die from uremia within 10 days. The survival time of the renal allograft was defined as the time from transplantation to the time of death. Only animals dying from surgical technical failure within the first 24 h after transplantation were excluded from the analysis.
Transfection of NFkB-decoy into donor kidney
We then examined the optimal conditions for the transfection of FTIC-labeled NFkB-decoy into the renal allografts by evaluating fluorescence intensity. The 100 mg NFkB-decoy labeled with FITC was dissolved in 0.5 ml saline containing Optison at three different concentrations (0%, 10%, or 25%, n¼4/each concentration). The solution was infused into the donor kidney followed by 1 min of ultrasound exposure in a similar manner to how we performed luciferase reporter gene transfection. The donor kidney was then transplanted into a Lewis recipient. The allograft was harvested on day 4, and the transfection efficiency was evaluated by examining fluorescence intensity in the renal tissue under a fluorescence microscopy.
Experimental design
Recipients were divided into five experimental groups according to the treatment protocol for the donor kidney as listed in Table 1 (n¼21/group in Groups 1-3 and 5; n410 in Group 4). The 100 mg of NFkB-decoy dissolved in 0.5 mL saline with 10% Optison (Group 1) or without Optison (Group 2) was infused into the donor kidney. The kidneys were exposed to ultrasound in a water bath for 1 min, and transplanted orthotopically into the Lewis recipients. As control groups, donor kidneys treated with the same amount of SC-decoy with ultrasound exposure with Optison (10%) (Group 3) or without Optison (Group 4) were transplanted into recipients. Additionally, recipients of renal allografts without any treatment served as another control group to further investigate the influence of the ultrasound-Optison-mediated procedure on the allografts (Group 5). Eleven animals from groups 1-3 and 5 were randomly selected and their donor kidneys were harvested on day 2, 4, or 6 and prepared for evaluation of ODN transfection, histological analysis, immunohistochemical study and RT-PCR analysis. The remaining 10 animals from each group were subjected to evaluation of graft survival.
Graft function
Twenty-four-hour urine was collected on alternate days following transplantation. Urine volume was measured serially, and urinary sediment was examined in each sample. We then assessed graft function more quantitatively by measuring serial serum creatinine levels in the recipients from Groups 1 and 3 (n¼10/group). Serum was obtained on alternate days by tail-vein puncture, and serum creatinine was measured by the Jaffe reaction method.
Graft morphology
Renal tissues were fixed in 4% paraformaldehyde in phosphate-buffered saline. Paraffin sections were stained with hematoxylin and eosin (HE), or periodic acid-Schiff (PAS), and then assessed by light microscopy. The animals were coded so that analysis was performed without any knowledge of which treatment each individual animal had received. Histological evaluation was performed on the basis of the Banff criteria.
Immunohistochemical study
Staining for ED1-and CD4-positive cells was performed by the alkaline phosphatase-anti-alkaline phosphatase (APAAP) method using a DAKO APAAP kit (DAKO Japan, Kyoto, Japan) according to the manufacturer's instructions. Monoclonal antibodies against ED1 and CD4 were purchased from Quantum Appligene (Parc d'Innovation, Illkirch, France). Staining for cytokines and adhesion molecules including IL-1, MCP-1, TNF-a, and ICAM-1 was performed by the immunoperoxidase method. Anti-rat rabbit polyclonal antibodies against IL-1, TNF-a, ICAM-1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), and MCP-1 (Pepro Tech, London, UK) were used as primary antibodies, and biotinated antirabbit goat Ig (Santa Cruz Biotechnology, Santa Cruz, CA, USA) was adopted as the secondary antibody. The reaction was visualized with 3, 3 0 -diaminobenzidine. The number of marker-positive cells was expressed as mean7standard deviation (M7s.d.) of cells per field of view (cells/FV). More than 20 fields of view were evaluated at a magnification of Â 400 for each section/ specimen. The expression of adhesion molecules and cytokines was quantified on a 0-4+ scale (4+¼dense).
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Reverse transcription-polymerase chain reaction (RT-PCR) assay
We evaluated the production of mRNA of major inflammatory mediators, including iNOS, IL-1, MCP-1, TNF-a and TGF-b1, and the adhesion molecules, ICAM-1 and VCAM-1, in the allografts from Groups 1 and 3 harvested on day 4, by semiquantitative RT-PCR method. RNA was extracted from tissues using RNeasy Total RNA Kits R (QUIAGEN, Hilden, Germany) according to the manufacturer's instructions. The quality of the RNA was confirmed by formaldehyde-agarose gel electrophoresis, and the cDNAs were prepared as described previously. 47 PCR was performed with a GeneAmp 9600 PCR system (Perkin-Elmer, Norwalk, CT, USA), using primers for iNOS, IL-1, MCP-1, TGF-b1, TNF-a, ICAM-1, VCAM-1, and b-actin. Primer sequences, annealing temperature, and number of cycles were as follows: 0 GAT CTT GAT CTT CAT GGT GCT AGG (601C, 23 cycles). DNA amplicans were electrophoresed on 1.5% agarose gels and visualized as bands under ultraviolet light with ethidium bromide staining (0.05 mg/ml for 10 min). The densities of respective bands were measured using the NIH image program (written by Wayne Rasband at US National Institutes of Health and available from the Internet by anonymous ftp from zippy.nimh.nih.gov). We performed individual experiment at least three times, and calculated the ratio of the density of target cDNA to that of b-actin in each experiment. The data were given as mean values in each group (Group 1, n¼4; Group 3, n¼6) and expressed as relative gene transcript level (X/b-actin).
Statistical analysis
The values obtained for urine volume and serum creatinine were analyzed by one-way analysis of variance (ANOVA). Graft survival was evaluated by Kaplan-Meier test. Unpaired Student's t-test was used to analyze the data on cellular infiltration from immunohistochemical study and the results of RT-PCR. MannWhitney U-test was performed for histological analysis and analysis of immunohistochemical data on the expression of adhesion molecules and cytokines. A Pvalue less than 0.05 was considered to be statistically significant.
